- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 142 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 240 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- December 2021
- 245 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- November 2021
- 175 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2022
- 140 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- September 2023
- 81 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- September 2023
- 180 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- November 2021
- 163 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- February 2024
- 180 Pages
Global
From €4724EUR$4,969USD£3,968GBP
- Report
- November 2023
- 170 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- September 2024
- 82 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2024
- 179 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP

The Hepatitis Drug market is a subset of the Infectious Diseases Drugs market, which includes treatments for a variety of illnesses caused by microorganisms. Hepatitis drugs are used to treat viral infections of the liver, including hepatitis A, B, and C. These drugs can be used to reduce symptoms, prevent further damage to the liver, and even cure the infection. Common treatments include antiviral medications, interferon, and direct-acting antivirals.
The Hepatitis Drug market is highly competitive, with many companies offering treatments for different types of hepatitis. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Bristol-Myers Squibb, and Novartis. Other companies such as Cipla, Mylan, and Teva Pharmaceuticals also offer treatments for hepatitis. Show Less Read more